Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaume Bonet

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Oncoimmunology|January 4, 2018
ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapySeandean Lykke Harwood, Ana Alvarez-Cienfuegos, Natalia Nuñez-Prado, et al.
Oncoimmunology|April 28, 2023
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor responseLaura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean L Harwood, et al.
Biochemistry|March 11, 2021
Modeling Immunity with Rosetta: Methods for Antibody and Antigen DesignClara T Schoeder, Samuel Schmitz, Jared Adolf-Bryfogle, et al.
Science (New York, N.Y.)|May 16, 2020
De novo protein design enables the precise induction of RSV-neutralizing antibodiesFabian Sesterhenn, Che Yang, Jaume Bonet, et al.
Nature Communications|August 24, 2016
Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritisSolveig K Sieberts, Fan Zhu, Javier García-García, et al.
Nature Communications|October 11, 2016
Erratum: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritisSolveig K Sieberts, Fan Zhu, Javier García-García, et al.
Nature Methods|June 3, 2020
Macromolecular modeling and design in Rosetta: recent methods and frameworksJulia Koehler Leman, Brian D Weitzner, Steven M Lewis, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Oncoimmunology|January 4, 2018
ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapySeandean Lykke Harwood, Ana Alvarez-Cienfuegos, Natalia Nuñez-Prado, et al.
Oncoimmunology|April 28, 2023
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor responseLaura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean L Harwood, et al.
Biochemistry|March 11, 2021
Modeling Immunity with Rosetta: Methods for Antibody and Antigen DesignClara T Schoeder, Samuel Schmitz, Jared Adolf-Bryfogle, et al.
Science (New York, N.Y.)|May 16, 2020
De novo protein design enables the precise induction of RSV-neutralizing antibodiesFabian Sesterhenn, Che Yang, Jaume Bonet, et al.
Nature Communications|August 24, 2016
Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritisSolveig K Sieberts, Fan Zhu, Javier García-García, et al.
Nature Communications|October 11, 2016
Erratum: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritisSolveig K Sieberts, Fan Zhu, Javier García-García, et al.
Nature Methods|June 3, 2020
Macromolecular modeling and design in Rosetta: recent methods and frameworksJulia Koehler Leman, Brian D Weitzner, Steven M Lewis, et al.
Pageof 5